Pharmacy Learning Network
@PharmaLearnNet
Followers
1K
Following
37
Media
468
Statuses
4K
Your Go-To Resource for Clinical and Regulatory Updates for Pharmacy Professionals @PopHealthNet
Joined August 2009
Dr Jennings shares findings from a new study evaluating RAAS inhibitors for the treatment of advanced chronic kidney disease.
0
0
1
A Class II #recall has been issued for a #prescription #Medication used to reverse the effects of nondepolarizing neuromuscular blocking agents after surgery.
0
0
1
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
402
649
3K
A prescription #drug used to manage hypertension is being recalled due to potential cross contamination.
0
0
0
Several lots of hand sanitizer are being recalled after the US Food and Drug Administration found undeclared methanol in one.
0
0
1
Nicole L Stout, DPT, CLT-LANA, FAPTA, shares her team’s research on distress screening and a quality improvement project to boost provider efficiency and close gaps in patients’ cancer #care .
0
0
0
Our readership reported staffing and scheduling issues as the leading cause of burnout among pharmacists. What actions, if any, has your organization taken to address burnout?
0
0
0
Check out our #quiz and test your knowledge on the recommended dosage of an H2 blocker for gastroesophageal reflux disease.
0
0
0
Dr Jennings shares new guidance from the US Food and Drug Administration and National Institutes of Health regarding the efficacy of 2 monoclonal antibodies against the #Omicron subvariants BQ.1 and BQ.1.1.
1
0
0
In the second part of his coverage of AHA Scientific Sessions 2022, Dr Jennings shares 2 randomized trials designed to compare diuretics for the treatment of hypertension and #HeartFailure .
0
0
0
In the latest issue of Talking Therapeutics, Dr Jennings highlights #data from American Heart Association Scientific Sessions 2022, including research into direct oral anticoagulants, a novel fibrate, and more.
0
0
0
Dr Jennings discusses the potential of xenotransplantation, the transplant of nonhuman tissues and organs into a human recipient, for alleviating organ scarcity across the world.
0
0
1
A Class I #Recall has been issued for atenolol tablets due to a bottle mistakenly containing clopidogrel.
0
0
0
Eric Tichy, PharmD, MBA, vice chair of pharmacy formulary, Mayo Clinic, offers insight into drug spending #trends that emerged over the course of 2021 and predicts how spending will continue to change.
0
1
0
In the latest installment of Talking Therapeutics, Dr Jennings shares a randomized study in which patients with mild to moderate cases of #COVID19 were treated with either ivermectin or placebo.
0
0
1
Social determinants of health, such as location and household income, influenced American Indian and Alaska Native individuals' use of clinical #pharmacy services.
0
0
0
Want to stay up-to-date on all the featured content from our trusted brands? Follow their respective pages, designed to curate the latest clinical insights, industry news, conference coverage, and more with thought leaders in #PopulationHealth and more!
0
0
1
Tracing reports by pharmacists resulted in cost savings by reducing leftover medications and prompting #Pharmaceutical interventions for #patientsafety.
0
0
0
Dr Jennings shares a new study which suggests lower doses of guideline-directed medical therapy might still produce a significant benefit for patients.
0
0
1
A Class II #recall has been issued for 103,150 vials of a #prescription bronchodilator following the report of a hair found in a vial.
0
0
0
In a session at #AMCPNexus 2022, speakers discussed the rise in #stimulant #overdoses with an emphasis on treatment options and how providers and health plans can better manage patients with stimulant use disorder.
0
0
0